185 related articles for article (PubMed ID: 16398842)
1. Attempted randomized controlled trial of pamidronate versus calcium and calcitriol supplements for management of steroid-induced osteoporosis in children and adolescents.
Brown JJ; Zacharin MR
J Paediatr Child Health; 2005 Nov; 41(11):580-2. PubMed ID: 16398842
[TBL] [Abstract][Full Text] [Related]
2. Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial.
Stoch SA; Saag KG; Greenwald M; Sebba AI; Cohen S; Verbruggen N; Giezek H; West J; Schnitzer TJ
J Rheumatol; 2009 Aug; 36(8):1705-14. PubMed ID: 19487264
[TBL] [Abstract][Full Text] [Related]
3. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium.
Sambrook PN; Kotowicz M; Nash P; Styles CB; Naganathan V; Henderson-Briffa KN; Eisman JA; Nicholson GC
J Bone Miner Res; 2003 May; 18(5):919-24. PubMed ID: 12733733
[TBL] [Abstract][Full Text] [Related]
4. [Secondary osteoporosis. Glucocorticoid induced osteoporosis in childhood : prophylaxis and treatment].
Tanaka H
Clin Calcium; 2007 Jul; 17(7):1114-9. PubMed ID: 17607080
[TBL] [Abstract][Full Text] [Related]
5. Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.
Cauza E; Etemad M; Winkler F; Hanusch-Enserer U; Partsch G; Noske H; Dunky A
J Clin Pharm Ther; 2004 Oct; 29(5):431-6. PubMed ID: 15482386
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
Cruse LM; Valeriano J; Vasey FB; Carter JD
J Clin Rheumatol; 2006 Oct; 12(5):221-5. PubMed ID: 17023807
[TBL] [Abstract][Full Text] [Related]
7. [Glucocorticoid induced osteoporosis in childhood: prophylaxis and treatment].
Tanaka H
Clin Calcium; 2009 Apr; 19(4):569-73. PubMed ID: 19329838
[TBL] [Abstract][Full Text] [Related]
8. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
Benchimol EI; Ward LM; Gallagher JC; Rauch F; Barrowman N; Warren J; Beedle S; Mack DR
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):538-45. PubMed ID: 18030230
[TBL] [Abstract][Full Text] [Related]
9. [Management of glucocorticoid-induced osteoporosis in childhood].
Tanaka H
Clin Calcium; 2006 Nov; 16(11):1879-86. PubMed ID: 17079856
[TBL] [Abstract][Full Text] [Related]
10. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
11. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
12. Effect of pamidronate on bone loss after kidney transplantation: a randomized trial.
Walsh SB; Altmann P; Pattison J; Wilkie M; Yaqoob MM; Dudley C; Cockwell P; Sweny P; Banks LM; Hall-Craggs M; Noonan K; Andrews C; Cunningham J
Am J Kidney Dis; 2009 May; 53(5):856-65. PubMed ID: 19393473
[TBL] [Abstract][Full Text] [Related]
13. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
Imanishi Y; Nishizawa Y
Clin Calcium; 2006 Nov; 16(11):1844-50. PubMed ID: 17079851
[TBL] [Abstract][Full Text] [Related]
14. Treatment of glucocorticoid-induced low bone mineral density in children: a systematic review.
Jayasena A; Atapattu N; Lekamwasam S
Int J Rheum Dis; 2015 Mar; 18(3):287-93. PubMed ID: 25923606
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis.
Lovell DJ; Glass D; Ranz J; Kramer S; Huang B; Sierra RI; Henderson CJ; Passo M; Graham B; Bowyer S; Higgins G; Rennebohm R; Schikler KN; Giannini E
Arthritis Rheum; 2006 Jul; 54(7):2235-42. PubMed ID: 16802360
[TBL] [Abstract][Full Text] [Related]
16. Long-term effects of pamidronate in thalassemic patients with severe bone mineral density deficits.
Leung TF; Chu Y; Lee V; Cheng FW; Leung WK; Shing MM; Li CK
Hemoglobin; 2009; 33(5):361-9. PubMed ID: 19814683
[TBL] [Abstract][Full Text] [Related]
17. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
Soen S
Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
[TBL] [Abstract][Full Text] [Related]
18. Pamidronate therapy for preventing steroid-induced osteoporosis in children with nephropathy.
Kim SD; Cho BS
Nephron Clin Pract; 2006; 102(3-4):c81-7. PubMed ID: 16282699
[TBL] [Abstract][Full Text] [Related]
19. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
20. [Glucocorticoid-induced osteoporosis].
Tóth M; Tulassay Z
Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
